Company intelligence / Profile preview
Confo Therapeutics
Ghent, Belgiumconfotherapeutics.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Confo Therapeutics has advanced its proprietary pipeline into the clinic, focusing on novel small molecule and antibody-based drugs targeting GPCRs for metabolic and endocrine diseases. The company’s technology enables access to previously undruggable targets. It has demonstrated proof-of-concept in vivo studies for its lead programs, secured major pharma partnerships, and raised significant funding to support ongoing clinical trials.
- Therapeutic areas
- EndocrinologyNeurologyMetabolic Disorders
- Modalities
- Small moleculesAntibody-based therapeutics (including single-domain antibodies/ConfoBodies)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Roche (drug discovery collaboration/licensing for neurological/developmental disorder target)Lundbeck (collaboration on CNS-related GPCR drug discovery)Regeneron Pharmaceuticals (antibody-based therapies using platform technology)
Beyond the preview
Go deeper on Confo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Confo Therapeutics.